Evaluation of the Efficacy of Aromatherapy on the Well-being of Healthcare Professionals
NCT ID: NCT05373849
Last Updated: 2023-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2022-05-09
2023-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Aromatherapy on the Delirium of Patients in Intensive Care Unit
NCT04529395
Effects of Stress-reducing Aromatherapy
NCT01307748
Aromatherapy for Stress and Burnout Among Healthcare Providers
NCT05114655
The Effect of Essential Oil Inhalation Patches on Perceived Burn-out & Stress on an Inpatient Medical-surgery Unit.
NCT06053450
Aromatherapy to Address Psychological Distress in Emergency Department Patients.
NCT07328412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To evaluate the efficacy of aromatherapy on anxiety of healthcare professionals;
2. To evaluate the efficacy of aromatherapy on stress symptoms of healthcate professionals;
3. To assess compliance with aromatherapy.
Conduct of research:
All participants included in the study will receive the study treatment (essential oils mixtures in inhaler sticks for 2 months) and the control (no intervention for 2 months), in random order. At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aromatherapy first then no intervention
The participant will receive the study treatment (essential oils mixture in inhaler sticks for 2 months) and the control (no intervention for 2 months). At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed
essentiel oil mixtures in inhaler sticks (step 1) - no intervention (step 2)
The participant will receive the study treatment (essential oils mixture in inhaler sticks for 2 months) and the control (no intervention for 2 months). At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed
no intervention (step 1) - essential oils mixture in inhaler sticks (step 2)
The participant will receive the control (no intervention for 2 months) and the study treatment (essential oils mixture in inhaler sticks for 2 months). At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed.
No intervention first then Aromatherapy
The participant will receive the control (no intervention for 2 months) and the study treatment (essential oils mixture in inhaler sticks for 2 months). At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed.
essentiel oil mixtures in inhaler sticks (step 1) - no intervention (step 2)
The participant will receive the study treatment (essential oils mixture in inhaler sticks for 2 months) and the control (no intervention for 2 months). At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed
no intervention (step 1) - essential oils mixture in inhaler sticks (step 2)
The participant will receive the control (no intervention for 2 months) and the study treatment (essential oils mixture in inhaler sticks for 2 months). At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
essentiel oil mixtures in inhaler sticks (step 1) - no intervention (step 2)
The participant will receive the study treatment (essential oils mixture in inhaler sticks for 2 months) and the control (no intervention for 2 months). At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed
no intervention (step 1) - essential oils mixture in inhaler sticks (step 2)
The participant will receive the control (no intervention for 2 months) and the study treatment (essential oils mixture in inhaler sticks for 2 months). At inclusion and at the end of each period, questionnaires of well-being, anxiety and stress will be completed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Working in a medical or surgical intensive care unit or in a operating room/anesthesia unit or in the emergency department;
* Agrees not to use any topical, oral or inhaled essential oils during the two study periods, other than those specified in the study protocol;
* Written informed consent;
Exclusion Criteria
* Known allergies to essential oils;
* Asthma;
* Scheduled departure from the unit;
* Antidepressant treatment or anxiolytic treatment;
* Taking topical, oral or inhaled essential oils durink the week prior to inclusion.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GHRMSA
Mulhouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A02995-36
Identifier Type: OTHER
Identifier Source: secondary_id
GHRMSA 1192
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.